Sagefield Capital’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Sagefield Capital’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,900	Closed	-$553K	–	109
2023 Q4	$553K	Buy	+8,900	New	+$221K	0.07%	79

Sagefield Capital's RYZB Position: Q1 2024 in Review

Sagefield Capital sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 8,900 shares — an estimated $553K sold.

Sagefield Capital first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $553K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Sagefield Capital reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Sagefield Capital sold 8,900 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $553K.
Sagefield Capital first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Sagefield Capital's RayzeBio, Inc. Common Stock position peaked at $553K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Sagefield Capital's 13F filing for Q1 2024, filed 15 May 2024.